Basic Information
Favrille Focuses on the Research, Development, and Commercialization of Targeted Immunotherapies for the Treatment of Cancer and Other Immune System Disorders. Favrille Was Founded in 2000 by Drs. Bob Shopes and Dan Gold.
Favrille,Inc.
SanDiego,California,United States of America
15~50 people
January 01, 2000
--